These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 9503533)
21. Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure. Binkley PF; Nunziata E; Haas GJ; Starling RC; Leier CV; Cody RJ Am Heart J; 2000 Jul; 140(1):34-42. PubMed ID: 10874261 [TBL] [Abstract][Full Text] [Related]
22. Angiotensin converting enzyme inhibition decreases systolic blood pressure more than diastolic pressure as shown by ambulatory blood pressure monitoring. Asmar RG; Pannier BM; Santoni JP; Safar ME J Hypertens Suppl; 1988 Dec; 6(3):S79-81. PubMed ID: 3225692 [TBL] [Abstract][Full Text] [Related]
23. [Perindopril and chronic heart failure]. Bounhoure JP Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():89-92. PubMed ID: 1793331 [TBL] [Abstract][Full Text] [Related]
24. Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers. Thuillez C; Richard C; Richer C; Loueslati H; Perret L; Auzépy P; Giudicelli JF J Hypertens Suppl; 1988 Dec; 6(3):S41-3. PubMed ID: 2852235 [TBL] [Abstract][Full Text] [Related]
25. Long-term tolerance of perindopril in hypertensive patients with impaired renal function. Dratwa M; Sennesael J; Taillard F; Baguet F; Suc JM; Lins RL; Lameire N J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S40-4. PubMed ID: 1725201 [TBL] [Abstract][Full Text] [Related]
26. [Hypotension followed the first dose of angiotensin-converting enzyme inhibitor in patients with heart failure (a multicenter clinical trial)]. Moiseev VS; Tereshchenko SN; Aleksandriia LG; Kobalava ZhD Ter Arkh; 2001; 73(9):61-6. PubMed ID: 11642085 [TBL] [Abstract][Full Text] [Related]
27. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function. Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536 [TBL] [Abstract][Full Text] [Related]
28. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J; Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472 [TBL] [Abstract][Full Text] [Related]
29. The angiotensin converting enzyme inhibitor perindopril improves survival after experimental myocardial infarction in pigs. Tobé TJ; de Langen CD; Weersink EG; van Wijngaarden J; Bel KJ; de Graeff PA; van Gilst WH; Wesseling H J Cardiovasc Pharmacol; 1992 May; 19(5):732-40. PubMed ID: 1381771 [TBL] [Abstract][Full Text] [Related]
30. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure. Squire IB; MacFayden RJ; Reid JL; Devlin A; Lees KR J Cardiovasc Pharmacol; 1996 May; 27(5):657-66. PubMed ID: 8859935 [TBL] [Abstract][Full Text] [Related]
31. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome. Gotsman I; Rubonivich S; Azaz-Livshits T Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235 [TBL] [Abstract][Full Text] [Related]
32. The acute effect of perindopril upon effort capacity in congestive heart failure. Zdrenghea D; Angheloiu O; Icusca G; Timiş D Rom J Intern Med; 1994; 32(4):265-9. PubMed ID: 7613498 [TBL] [Abstract][Full Text] [Related]
33. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure. Sami M Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688 [TBL] [Abstract][Full Text] [Related]
34. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI]. Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514 [TBL] [Abstract][Full Text] [Related]
35. [Return of circadian blood pressure and heart rate changes in patients with heart transplants]. Bracht C; von Hoyningen-Huene K; Uberfuhr P; Reichart B; Höfling B Z Kardiol; 1992; 81 Suppl 2():9-11. PubMed ID: 1355327 [TBL] [Abstract][Full Text] [Related]
36. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
37. [Changes in venous tonus in rats with heart failure during acute and chronic perindopril administration]. Moleva EB; Gorodetskaia EA; Zakharova NV; Medvedev OS Eksp Klin Farmakol; 1996; 59(4):15-7. PubMed ID: 9026180 [TBL] [Abstract][Full Text] [Related]
38. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group. Vítovec J; Spinar J Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492 [TBL] [Abstract][Full Text] [Related]
39. [Prognostic value of detection of arterial hypotensive episodes in patients with chronic heart failure]. Serov VA; Shutov AM; Serova DV; Shmel'kova EIu; Shevchenko SV Ter Arkh; 2014; 86(4):8-12. PubMed ID: 24864461 [TBL] [Abstract][Full Text] [Related]
40. Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure. Reid JL; MacFadyen RJ; Squire IB; Lees KR Am J Cardiol; 1993 Jun; 71(17):57E-60E. PubMed ID: 8392282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]